rs326214
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000706887.1(MADD):c.1041G>A(p.Glu347Glu) variant causes a synonymous change. The variant allele was found at a frequency of 0.64 in 1,613,686 control chromosomes in the GnomAD database, including 338,758 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.57 ( 26060 hom., cov: 31)
Exomes 𝑓: 0.65 ( 312698 hom. )
Consequence
MADD
ENST00000706887.1 synonymous
ENST00000706887.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.77
Publications
51 publications found
Genes affected
MADD (HGNC:6766): (MAP kinase activating death domain) Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells by cytoplasmic adaptor proteins. The protein encoded by this gene is a death domain-containing adaptor protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activated protein kinase (MAPK) and propagate the apoptotic signal. It is membrane-bound and expressed at a higher level in neoplastic cells than in normal cells. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
MADD Gene-Disease associations (from GenCC):
- neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotoniaInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P
- syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 11-47276809-G-A is Benign according to our data. Variant chr11-47276809-G-A is described in ClinVar as Benign. ClinVar VariationId is 1243998.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MADD | NM_001376571.1 | c.1041G>A | p.Glu347Glu | synonymous_variant | Exon 5 of 37 | NP_001363500.1 | ||
| MADD | NM_003682.4 | c.1041G>A | p.Glu347Glu | synonymous_variant | Exon 5 of 36 | NP_003673.3 | ||
| MADD | NM_001376572.1 | c.1041G>A | p.Glu347Glu | synonymous_variant | Exon 5 of 37 | NP_001363501.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MADD | ENST00000706887.1 | c.1041G>A | p.Glu347Glu | synonymous_variant | Exon 5 of 37 | ENSP00000516604.1 |
Frequencies
GnomAD3 genomes AF: 0.565 AC: 85830AN: 151888Hom.: 26041 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
85830
AN:
151888
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.593 AC: 149049AN: 251424 AF XY: 0.603 show subpopulations
GnomAD2 exomes
AF:
AC:
149049
AN:
251424
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.647 AC: 946136AN: 1461680Hom.: 312698 Cov.: 50 AF XY: 0.647 AC XY: 470119AN XY: 727166 show subpopulations
GnomAD4 exome
AF:
AC:
946136
AN:
1461680
Hom.:
Cov.:
50
AF XY:
AC XY:
470119
AN XY:
727166
show subpopulations
African (AFR)
AF:
AC:
11903
AN:
33480
American (AMR)
AF:
AC:
25153
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
19936
AN:
26130
East Asian (EAS)
AF:
AC:
12192
AN:
39696
South Asian (SAS)
AF:
AC:
46324
AN:
86244
European-Finnish (FIN)
AF:
AC:
31386
AN:
53382
Middle Eastern (MID)
AF:
AC:
4086
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
756614
AN:
1111870
Other (OTH)
AF:
AC:
38542
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
16541
33082
49622
66163
82704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19096
38192
57288
76384
95480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.565 AC: 85898AN: 152006Hom.: 26060 Cov.: 31 AF XY: 0.559 AC XY: 41494AN XY: 74284 show subpopulations
GnomAD4 genome
AF:
AC:
85898
AN:
152006
Hom.:
Cov.:
31
AF XY:
AC XY:
41494
AN XY:
74284
show subpopulations
African (AFR)
AF:
AC:
14782
AN:
41440
American (AMR)
AF:
AC:
9521
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
2622
AN:
3468
East Asian (EAS)
AF:
AC:
1591
AN:
5182
South Asian (SAS)
AF:
AC:
2562
AN:
4808
European-Finnish (FIN)
AF:
AC:
6025
AN:
10560
Middle Eastern (MID)
AF:
AC:
208
AN:
294
European-Non Finnish (NFE)
AF:
AC:
46492
AN:
67962
Other (OTH)
AF:
AC:
1342
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1732
3464
5196
6928
8660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1600
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 05, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Deeah syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.